These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 26391645)

  • 1. CXCR1 knockdown improves the sensitivity of osteosarcoma to cisplatin.
    Han XG; Du L; Qiao H; Tu B; Wang YG; Qin A; Dai KR; Fan QM; Tang TT
    Cancer Lett; 2015 Dec; 369(2):405-15. PubMed ID: 26391645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCR1/Akt signaling activation induced by mesenchymal stem cell-derived IL-8 promotes osteosarcoma cell anoikis resistance and pulmonary metastasis.
    Du L; Han XG; Tu B; Wang MQ; Qiao H; Zhang SH; Fan QM; Tang TT
    Cell Death Dis; 2018 Jun; 9(7):714. PubMed ID: 29915309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-8 Induces Expression of FOXC1 to Promote Transactivation of CXCR1 and CCL2 in Hepatocellular Carcinoma Cell Lines and Formation of Metastases in Mice.
    Huang W; Chen Z; Zhang L; Tian D; Wang D; Fan D; Wu K; Xia L
    Gastroenterology; 2015 Oct; 149(4):1053-67.e14. PubMed ID: 26065367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TIMP3 Overexpression Improves the Sensitivity of Osteosarcoma to Cisplatin by Reducing IL-6 Production.
    Han XG; Mo HM; Liu XQ; Li Y; Du L; Qiao H; Fan QM; Zhao J; Zhang SH; Tang TT
    Front Genet; 2018; 9():135. PubMed ID: 29731768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCR1 promotes malignant behavior of gastric cancer cells in vitro and in vivo in AKT and ERK1/2 phosphorylation.
    Wang J; Hu W; Wu X; Wang K; Yu J; Luo B; Luo G; Wang W; Wang H; Li J; Wen J
    Int J Oncol; 2016 May; 48(5):2184-96. PubMed ID: 26983663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGM2 knockdown reverses cisplatin chemoresistance in osteosarcoma.
    Li C; Cai J; Ge F; Wang G
    Int J Mol Med; 2018 Oct; 42(4):1799-1808. PubMed ID: 30015899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knockdown of Akt sensitizes osteosarcoma cells to apoptosis induced by cisplatin treatment.
    Zhang G; Li M; Zhu X; Bai Y; Yang C
    Int J Mol Sci; 2011; 12(5):2994-3005. PubMed ID: 21686164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXC receptor-1 silencing inhibits androgen-independent prostate cancer.
    Shamaladevi N; Lyn DA; Escudero DO; Lokeshwar BL
    Cancer Res; 2009 Nov; 69(21):8265-74. PubMed ID: 19861539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-8/CXCL8 is a growth factor for human lung cancer cells.
    Zhu YM; Webster SJ; Flower D; Woll PJ
    Br J Cancer; 2004 Nov; 91(11):1970-6. PubMed ID: 15545974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotensin signaling regulates stem-like traits of glioblastoma stem cells through activation of IL-8/CXCR1/STAT3 pathway.
    Zhou J; Yi L; Ouyang Q; Xu L; Cui H; Xu M
    Cell Signal; 2014 Dec; 26(12):2896-902. PubMed ID: 25200966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-32 stimulates osteosarcoma cell invasion and motility via AKT pathway-mediated MMP-13 expression.
    Zhou Y; Hu Z; Li N; Jiang R
    Int J Mol Med; 2015 Jun; 35(6):1729-33. PubMed ID: 25846944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adenovirus mediated antisense c-myc gene on the chemotherapy sensitivity of osteosarcoma cells to cisplatin].
    Yang DS; Xie XK; Ye ZM; Tao HM
    Zhonghua Wai Ke Za Zhi; 2005 Jun; 43(12):799-802. PubMed ID: 16083584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syndecan-2 affects the basal and chemotherapy-induced apoptosis in osteosarcoma.
    Orosco A; Fromigué O; Bazille C; Entz-Werle N; Levillain P; Marie PJ; Modrowski D
    Cancer Res; 2007 Apr; 67(8):3708-15. PubMed ID: 17440083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent blockade of NF-κB and Akt pathways potentiates cisplatin's antitumor activity in vivo.
    Sun H; Zheng X; Wang Q; Yan J; Li D; Zhou Y; Lin Y; Zhang L; Wang X
    Anticancer Drugs; 2012 Nov; 23(10):1039-46. PubMed ID: 22760211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of CABYR-a/b increases chemosensitivity of human non-small cell lung cancer cells through inactivation of Akt.
    Qian Z; Li M; Wang R; Xiao Q; Wang J; Li M; He D; Xiao X
    Mol Cancer Res; 2014 Mar; 12(3):335-47. PubMed ID: 24362251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement effect of adenovirus-mediated antisense c-myc and caffeine on the cytotoxicity of cisplatin in osteosarcoma cell lines.
    Xie XK; Yang DS; Ye ZM; Tao HM
    Chemotherapy; 2009; 55(6):433-40. PubMed ID: 19996588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma.
    Tu B; Du L; Fan QM; Tang Z; Tang TT
    Cancer Lett; 2012 Dec; 325(1):80-8. PubMed ID: 22743617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CXCR1 tail mediates beta1 integrin-dependent cell migration via MAP kinase signaling.
    Liu-Bryan R; Pay S; Schraufstatter IU; Rose DM
    Biochem Biophys Res Commun; 2005 Jun; 332(1):117-25. PubMed ID: 15896307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiles classify human osteosarcoma xenografts according to sensitivity to doxorubicin, cisplatin, and ifosfamide.
    Bruheim S; Xi Y; Ju J; Fodstad O
    Clin Cancer Res; 2009 Dec; 15(23):7161-9. PubMed ID: 19920113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heat shock protein 27 protects L929 cells from cisplatin-induced apoptosis by enhancing Akt activation and abating suppression of thioredoxin reductase activity.
    Zhang Y; Shen X
    Clin Cancer Res; 2007 May; 13(10):2855-64. PubMed ID: 17504983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.